DISPATCHES FROM INTERPHEX

New DFS Unit Built on Technology, R&D and Manufacturing, says Capsugel

By Dan Stanton

- Last updated on GMT

Related tags: Dosage forms

Following a busy few months, Capsugel spoke about the formation of its Dosage Form Solutions Unit, its technology and the integration of Encap at this year's Interphex in New York.

According to Aresh Tahbez, the Director of Global Marketing at Capsugel’s recently formed Dosage Forms Solutions (DFS) Unit, the Unit is built upon three areas: Capsugel’s technologies, its R&D capabilities and its manufacturing infrastructure.

He also told us that Encap – acquired in March this year​ - was being integrated well and was “providing Capsugel DFS with a leadership position in liquid-filled hard capsules.”

Capsugel was also showcasing its CFS1200 liquid-filling and sealing machine which can be used for clinical batches or upscaled for larger manufacturing scales, and can be seen in action in the video above.

Related news

Show more

Related products

Flow Cytometry Services

Flow Cytometry Services

Q2 Solutions | 01-Jun-2020 | Data Sheet

We are an established leader in flow cytometry services for clinical trials. Our technologies and solutions meet the growing global demand for enhanced...

Local lab Data Management

Local lab Data Management

Q2 Solutions | 01-May-2020 | Data Sheet

When a clinical trial requires local or point-of-care laboratory testing, managing the resulting data can be a significant burden to both the sponsor and...

Q2 Solutions: Corporate Brochure

Q2 Solutions: Corporate Brochure

Q2 Solutions | 17-Apr-2020 | Product Brochure

We are an innovative, progressive and responsive partner with the global experience, medical expertise and focus on quality that is integral to drug, medical...

Follow us

Products

View more

Webinars